Treatment of Sodium Retention in Liver Cirrhosis With Dexamethasone
Status:
Terminated
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
Accumulation of salt and water in patients with liver disease (so called liver cirrhosis) is
possibly related to the increased effect of steroid hormones on salt reabsorption in the
kidney. By reducing overall steroid production with the dexamethasone the accumulation of
salt and water could be prevented.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital Inselspital, Berne
Collaborators:
University Hospital, Geneva University of Lausanne Hospitals